Trevena

$2.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-3.61%) Today
+$0.02 (+0.84%) As of 5:10 PM EST after-hours

Why Robinhood?

You can buy or sell Trevena and other stocks, options, and ETFs commission-free!

About TRVN

Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA. The listed name for TRVN is Trevena, Inc. Common Stock.

CEO
Carrie L. Bourdow
Employees
24
Headquarters
Chesterbrook, Pennsylvania
Founded
2007
Market Cap
376.87M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.83M
High Today
$2.53
Low Today
$2.40
Open Price
$2.48
Volume
4.21M
52 Week High
$3.68
52 Week Low
$0.46

Collections

TRVN Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like